Back to top

ResMed Inc.Enters Oversold Territory

Read MoreHide Full Article

ResMed Inc.’s (RMD - Free Report) share price has entered into oversold territory with an RSI value of 25.73. The Zacks Consensus Estimate on ResMed Inc.’s earnings for the full year period have moved higher by 1 cent over the past two months to $2.26 per share. Currently, ResMed a Zacks #1 Rank (“Strong Buy”), suggesting that now might be a good time to get in on (RMD - Free Report) after its recent drop.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

ResMed Inc. (RMD) - free report >>

More from Zacks Tale of the Tape

You May Like